Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NCS Multistage Holdings (NCSM) Asset Writedowns and Impairment (2016 - 2025)

NCS Multistage Holdings (NCSM) has 9 years of Asset Writedowns and Impairment data on record, last reported at $367000.0 in Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 92.15% year-over-year to $367000.0; the TTM value through Dec 2025 reached $857000.0, down 24.56%, while the annual FY2025 figure was $857000.0, 24.56% down from the prior year.
  • Asset Writedowns and Impairment reached $367000.0 in Q4 2025 per NCSM's latest filing, up from $299000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $1.9 million in Q4 2021 and bottomed at -$1.7 million in Q4 2022.
  • Average Asset Writedowns and Impairment over 5 years is $258900.0, with a median of $246000.0 recorded in 2024.
  • The widest YoY moves for Asset Writedowns and Impairment: up 3116.07% in 2022, down 189.7% in 2022.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $1.9 million in 2021, then tumbled by 189.7% to -$1.7 million in 2022, then skyrocketed by 157.96% to $979000.0 in 2023, then crashed by 80.49% to $191000.0 in 2024, then surged by 92.15% to $367000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were $367000.0 in Q4 2025, $299000.0 in Q3 2025, and $226000.0 in Q2 2025.